TURCHETTI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 29.815
EU - Europa 22.247
AS - Asia 14.275
SA - Sud America 3.035
AF - Africa 318
Continente sconosciuto - Info sul continente non disponibili 128
OC - Oceania 57
AN - Antartide 1
Totale 69.876
Nazione #
US - Stati Uniti d'America 28.536
SG - Singapore 5.530
RU - Federazione Russa 5.170
GB - Regno Unito 4.532
IT - Italia 4.476
CN - Cina 3.698
BR - Brasile 2.534
DE - Germania 2.296
UA - Ucraina 1.973
VN - Vietnam 1.828
DK - Danimarca 1.239
KR - Corea 1.066
CA - Canada 1.037
HK - Hong Kong 778
SE - Svezia 462
FR - Francia 382
FI - Finlandia 358
IE - Irlanda 330
IN - India 310
PL - Polonia 267
AR - Argentina 199
NL - Olanda 194
MX - Messico 159
ES - Italia 144
ZA - Sudafrica 137
BD - Bangladesh 131
EU - Europa 126
TR - Turchia 123
ID - Indonesia 122
JP - Giappone 122
EC - Ecuador 100
IL - Israele 92
IQ - Iraq 84
AT - Austria 82
BE - Belgio 59
AU - Australia 51
LT - Lituania 49
CH - Svizzera 47
PK - Pakistan 44
CO - Colombia 43
MA - Marocco 39
PH - Filippine 38
UZ - Uzbekistan 37
PE - Perù 36
VE - Venezuela 36
PT - Portogallo 34
MY - Malesia 33
PY - Paraguay 33
CL - Cile 29
TW - Taiwan 28
AE - Emirati Arabi Uniti 26
JO - Giordania 26
SA - Arabia Saudita 26
IR - Iran 25
RO - Romania 22
KE - Kenya 21
EG - Egitto 20
JM - Giamaica 18
BG - Bulgaria 15
DO - Repubblica Dominicana 15
NP - Nepal 15
TH - Thailandia 15
UY - Uruguay 14
GR - Grecia 13
KZ - Kazakistan 13
TN - Tunisia 13
AZ - Azerbaigian 12
RS - Serbia 12
ML - Mali 11
NG - Nigeria 11
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 10
DZ - Algeria 10
ET - Etiopia 10
SN - Senegal 10
AL - Albania 9
BA - Bosnia-Erzegovina 9
SK - Slovacchia (Repubblica Slovacca) 9
CY - Cipro 8
HN - Honduras 8
LV - Lettonia 8
OM - Oman 8
PA - Panama 8
SI - Slovenia 8
GH - Ghana 7
HR - Croazia 7
PS - Palestinian Territory 7
TT - Trinidad e Tobago 7
BY - Bielorussia 6
HU - Ungheria 6
AM - Armenia 5
BO - Bolivia 5
GY - Guiana 5
LU - Lussemburgo 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
AO - Angola 4
BH - Bahrain 4
CR - Costa Rica 4
GD - Grenada 4
Totale 69.807
Città #
Dallas 6.138
Singapore 3.104
Southend 3.055
Chandler 2.063
Beijing 1.902
Woodbridge 1.736
Houston 1.561
Ashburn 1.519
Ann Arbor 1.350
San Mateo 1.164
Jacksonville 945
Moscow 856
Dearborn 840
Daejeon 815
Fairfield 780
Hong Kong 756
Falls Church 629
Cambridge 603
Wilmington 571
Pisa 547
Los Angeles 468
Seattle 442
Ho Chi Minh City 427
Hefei 408
Dong Ket 397
Stevenage 379
Boardman 367
Portsmouth 357
Montréal 339
The Dalles 331
Lawrence 325
Milan 316
Dublin 304
Rome 281
New York 274
São Paulo 271
Munich 264
Hanoi 245
Seoul 245
Warsaw 235
Beauharnois 228
Brooklyn 219
Santa Clara 203
Fremont 191
Buffalo 189
Ottawa 171
Redwood City 147
Old Bridge 129
Salerno 128
London 118
Denver 112
Montreal 108
Stockholm 102
Chicago 101
San Diego 99
Council Bluffs 97
Johannesburg 96
Florence 94
Tokyo 93
Mcallen 91
Poplar 91
Atlanta 87
Chennai 87
Rio de Janeiro 75
Tel Aviv 74
Phoenix 73
Orem 70
Toronto 68
Nuremberg 65
Mexico City 64
Bologna 62
Boston 60
Norwalk 59
Ankara 58
Guangzhou 58
Helsinki 57
Wuxi 56
San Francisco 54
Manchester 52
Serra 51
Belo Horizonte 49
Da Nang 49
Brasília 48
Turin 46
Haiphong 40
Mumbai 39
Frankfurt am Main 38
Biên Hòa 37
Guayaquil 37
Vienna 37
Porto Alegre 36
Duncan 34
Paris 34
Tashkent 34
Torino 34
Shanghai 33
Amsterdam 32
Redmond 32
Curitiba 31
Foggia 31
Totale 42.397
Nome #
Innovation in rehabilitation technology: technological opportunities and socio-economic implications 825
Nutri-Score and Food Perception: Insights from an Italian Study 705
On Robots and Insurance 531
A cost-effectiveness analysis for total knee arthroplasty telerehabilitation: proof of concept of a decision model 473
PDTA per la Chirurgia bariatrica: l'esperienza di sei centri italiani 469
A new organizational integrated home-care model: An Italian pilot study 457
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 423
The impact of cardiovascular disease and type 2 diabetes mellitus on social cost in chronic kidney disease patients in Italy 403
How deregulation shapes market structure and industry efficiency. The case of the Italian motor insurance industry 392
Economic evaluation of da Vinci-assisted robotic surgery:a systematic review 377
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 356
Early Stage Economic Evaluation of Caretoy System for Early Intervention In Preterm Infants At Risk of Neurodevelopmental Disorders 334
A budget impact analysis (BIA) of the use of paracalcitol for the treatment of a secondary hyperparathyroidism (SHPT) in end stage renal disease patients 331
La logistica sanitaria nelle Aziende Sanitarie e Ospedaliere del Servizio Sanitario Nazionale 331
Acceptability of robotic technology in neuro-rehabilitation: Preliminary results on chronic stroke patients 329
The Effect of using Serifs in Brand Names on Luxury Perception 329
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 318
Cost-effectiveness (CE) of imaging-guided strategies for the diagnosis of coronary artery disease (CAD): results from the EVINCI study 314
Marketing per la Sanità. Logiche e strumenti 300
Budget impact analysis of belimumab in treating Systemic Lupus Erythematosus 299
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 298
Comparative health technology assessment of robotic-assisted, direct manual laparoscopic and open surgery: a prospective study 293
Health technology assessment. Evaluation of biomedical innovative technologies 288
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 288
Early assessment of neuro-rehabilitation technology: a case study 285
Tele-monitoring of ventilator-dependent patients: A European Respiratory Society Statement 285
The opportunity of treating type II diabetes with DPP4i: an economic evaluation versus conventional treatment in the Italian setting 284
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 282
A Pitcure of Private Health Insurance Policyholders in Italy 282
Model-Based Techniques In The Early Phases of The Medical Device Development: A Systematic Literature Review 281
Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis 277
Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis 276
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 276
Early assessment of neuro-rehabilitation technology 274
Scoping review and bibliometric analysis of Big Data applications for Medication adherence: An explorative methodological study to enhance consistency in literature 270
Health Technology Assessment Needs Information Technology: The Experience From The First Italian Study On The Da Vinci Surgical Robot 266
Cost analysis of the robotic surgery in Italy 265
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 263
A systematic literature review of the economic impact of ankylosing spondylitis 262
An economic evaluation of different procedures in bariatric surgery 262
Interactive business models for Telerehabilitation after Total Knee Replacement: Preliminary results from Tuscany 260
Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies 260
Early assessment of neuro – rehabilitation technology: a case study 256
The COVID-19 outbreak: From “black swan” to global challenges and opportunities 256
A novel explanation of why organizations fail to adopt proven technologies: The special case of imaging in the healthcare sector 253
Economic evaluation of the acquisition of a remote monitoring system in the framework of a 'chronic care model' 251
Budget impact analysis of the use of extended half-life recombinant factor VIII (Efmoroctog alfa) for the treatment of congenital haemophilia A: The Italian national health system perspective 250
Effectiveness and costs of different strategies for the diagnosis of stable coronary artery disease: results from the EVINCI study 248
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 248
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 248
Is EEG Suitable for Marketing Research? A Systematic Review 248
A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus 247
Assessment of the economic impact of Belimumab for the treatment of systemic lupus erithematosus in the Italian setting: a cost-effectiveness analysis 246
Analisi di budget impact sull’utilizzo di paracalcitolo nel trattamento dell’iperparatiroidismo secondario associato a malattia renale cronica 246
Topic modeling and user network analysis on twitter during world lupus awareness day 245
Innovation in rehabilitation technology: technological opportunities and socio-economic implications 244
Natural and man-made disasters: challenges and international perspectives for insurance 243
A registry for the collection of data in cochlear implant patients 242
Innovation in rehabilitation technology 240
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 236
Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy 235
How colour saturation accelerates purchase behaviour, and influences food choice: 234
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 234
Belimumab nel trattamento del Lupus Eritematoso Sistemico: valutazione di una nuova tecnologia sanitaria 233
Do Socioeconomic Inequalities Impact The Social Cost Of Chronic Kidney Disease In Italy? 233
Assessing the value of the use of diagnostic technology: trade offs for GPs 233
Early timing of the use of paricalcitol for the treatment of secondary hyperparathyroidism (SHPT) in chronic kidney patients (CKD): a budget impact analysis (BI) 232
The quality of life of patients treated with robotic versus traditional surgery: results from an Italian observational multicenter study 231
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 229
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 229
Alfonso Desiata. L'Assicuratore, l'Intellettuale, la Persona 228
Social costs of different procedures in bariatric surgery in patients with obesity-related comorbidities 228
L’Economia digitale e il settore assicurativo 227
Dentro, attraverso, oltre la crisi: il caso El.En 227
Economic impact of drug addiction interventions in adult population: The Peru case 227
Technology and innovative services. Toward a megamarket response to aging 225
Allocazione delle Risorse al Sistema della Ricerca e Competitività del Sistema delle Imprese: una Chiave di Lettura 224
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 224
Telerehabilitation after total knee replacement in Italy: cost-effectiveness and cost-utility analysis of a mixed telerehabilitation-standard rehabilitation programme compared with usual care 224
Il PDTA del paziente con adenocarcinoma gastrico: analisi organizzativa di cinque centri del Veneto 222
Cost-effectiveness of Different Strategies for the Diagnosis of Stable Coronary Artery Disease: Results from the Evinci Study 221
Economic Impact of Employment Status on The Social Cost of Morbid Obese Patients Submitted to Bariatric Surgery 221
The Impact of Robotic Technology on Neuro-Rehabilitation: Preliminary Results on Acceptability And Effectiveness 221
PADLOck: Thefts of medicines and Hospital Pharmacies' safety. An Italian study 221
Evidence-gathering across industry and academia on early Health Technology Assessment (HTA) of medical devices: survey design and piloting 221
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 220
The organizational analysis of ‘patient diagnostic therapeutic pathway’ for patients with gastric cancer in five centres of the Veneto Region (Italy) 220
Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: The Italian National Health System perspective 220
Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF 220
The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease 219
Cochlear implant in prelingual deafened oralist adults: Speech perception outcome, subjective benefits and quality of life improvement 218
Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy 217
Telerehabilitation after Total Knee Replacement: Preliminary Cost-Utility Analysis of an Innovative Device 217
Il Governo della Sanità 216
The social cost of chronic kidney disease in Italy 216
Are drug procurement procedure and award criteria in EU hospital setting standardized and do they take into account effective supply quality? 215
WEB SURVEY AND FOCUS GROUPS EXPLORING KNOWLEDGE, NEEDS AND EXPECTATIONS AMONG SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS 215
Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study 215
Anatomic and functional imaging to predict long-term outcome and benefits of early revascularization in patients with suspected coronary artery disease: results from the EVINCI study 214
La Pubblicità in Sanità: Opportunità e Minacce di uno Strumento Potente 213
Totale 27.759
Categoria #
all - tutte 367.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 367.378


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.392 0 0 0 0 0 844 549 445 528 341 697 988
2021/20224.643 151 871 157 297 95 95 609 997 311 480 146 434
2022/20234.347 366 365 139 759 552 736 28 338 645 99 185 135
2023/20242.071 230 107 335 92 70 271 220 115 79 75 132 345
2024/202513.881 160 164 856 465 537 1.088 2.179 3.849 1.179 566 1.896 942
2025/202621.258 1.956 5.594 4.216 4.334 4.131 1.027 0 0 0 0 0 0
Totale 70.297